Coloplast A/S
COLO-B.CO

$27.94 B
Marketcap
$124.18
Share price
Country
$-1.05
Change (1 day)
$138.90
Year High
$105.71
Year Low

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

marketcap

P/E ratio for Coloplast A/S (COLO-B.CO)

P/E ratio as of 2024: 38.95

According to Coloplast A/S's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 38.95. At the end of 2023 the company had a P/E ratio of 33.67.

P/E ratio history for Coloplast A/S from 2002 to 2024

PE ratio at the end of each year

Year P/E ratio
2024 38.95
2023 33.67
2022 35.03
2021 44.39
2020 50.83
2019 45.22
2018 36.72
2017 28.56
2016 34.62
2015 111.10
2014 43.57
2013 24.38
2012 23.28
2011 18.55
2010 22.40
2009 20.53
2008 23.63
2007 62.98
2006 46.95
2005 31.99
2004 46.09
2003 44.74
2002 32.43